72090-04-1 Usage
Uses
Used in Nutritional Supplements:
L-arginine mono(3-methyl-2-oxovalerate) is used as a nutritional supplement to enhance the bioavailability of L-arginine, which is essential for protein synthesis and supports various bodily functions. The improved stability and potential health benefits make it a valuable addition to dietary supplements.
Used in Sports Supplements:
In the sports supplement industry, L-arginine mono(3-methyl-2-oxovalerate) is used as a performance enhancer due to its potential effects on cardiovascular health and blood flow. Athletes may benefit from the compound's ability to support immune system health and improve blood vessel dilation, which can contribute to better athletic performance.
Used in Medicinal Research:
L-arginine mono(3-methyl-2-oxovalerate) is utilized in medicinal research for its potential therapeutic effects. L-arginine mono(3-methyl-2-oxovalerate) is being studied for its possible impact on cardiovascular health, as well as its potential to support immune system function and enhance blood flow. Further research is necessary to fully understand its properties and potential applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 72090-04-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,0,9 and 0 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 72090-04:
(7*7)+(6*2)+(5*0)+(4*9)+(3*0)+(2*0)+(1*4)=101
101 % 10 = 1
So 72090-04-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H14N4O2.C6H10O3/c7-4(5(11)12)2-1-3-10-6(8)9;1-3-4(2)5(7)6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10);4H,3H2,1-2H3,(H,8,9)
72090-04-1Relevant articles and documents
Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
-
, (2008/06/13)
Novel compounds are prepared by reacting ornithine or arginine with alpha keto analogs of branched chain essential amino acids, namely valine, leucine and isoleucine. The compounds are useful either individually or as a mixture in the treatment of hepatic disorders which are characterized by hyperammonemia and portal systemic encephalopathy. Use of these compounds in treatment of renal failure also appears promising.
